WO2000076459A2 - Bains d'huile - Google Patents

Bains d'huile Download PDF

Info

Publication number
WO2000076459A2
WO2000076459A2 PCT/EP2000/005173 EP0005173W WO0076459A2 WO 2000076459 A2 WO2000076459 A2 WO 2000076459A2 EP 0005173 W EP0005173 W EP 0005173W WO 0076459 A2 WO0076459 A2 WO 0076459A2
Authority
WO
WIPO (PCT)
Prior art keywords
acid
carbon atoms
radical
alkyl
contain
Prior art date
Application number
PCT/EP2000/005173
Other languages
German (de)
English (en)
Other versions
WO2000076459A3 (fr
Inventor
Hermann Hensen
Celia Kosboth
Werner Seipel
Anke Eggers
Josef Koester
Original Assignee
Cognis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognis Deutschland Gmbh filed Critical Cognis Deutschland Gmbh
Publication of WO2000076459A2 publication Critical patent/WO2000076459A2/fr
Publication of WO2000076459A3 publication Critical patent/WO2000076459A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/26—Optical properties
    • A61K2800/262—Transparent; Translucent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Definitions

  • tensides and oils can be mixed in any ratio depending on the desired application.
  • These formulations previously contained alkanolamides, which belong to the "nitrosamine-forming substances". Nitrosamines in any small amount, not because of their presence in cosmetics, but if they get into the body, have a harmful effect. For this reason, cosmetic preparations which are not Alkanolamides contain, desirable, however, the removal of alkanolamides from the surfactant mixtures leads to cloudy formulations when mixed with oil components.
  • the object of the present invention was therefore to provide clear by blending alkanols lamidELI surfactant mixtures with defined amounts of oily substances, anhydrous Kosmeti ⁇ cal preparations are available that show no turbidity even when stored.
  • Alkoxylated carboxylic acid esters which are necessarily contained in the agents according to the invention as component (a1), are known from the prior art.
  • such alkoxylated carboxylic acid esters are accessible by esterification of alkoxylated carboxylic acids with alcohols.
  • the compounds are preferably prepared by reacting carboxylic acid esters with alkylene oxides using catalysts, in particular using calcined hydrotalcite according to German Offenlegungsschrift DE 3914131 A, which provide compounds with a restricted homolog distribution.
  • Both carboxylic acid esters of monohydric alcohols and polyhydric alcohols can be alkoxylated by this process. According to the present invention, preference is given to alkoxylated carboxylic acid esters of monohydric alcohols which follow the general formula (I)
  • R CO stands for an aliphatic acyl radical derived from a carboxylic acid
  • AlkO for alkylene oxide
  • R 2 for an aliphatic alkyl radical derived from a monohydric aliphatic alcohol.
  • Particularly suitable are alkoxylated carboxylic acid esters of the formula (I) in which R 1 CO for an aliphatic acyl radical having 6 to 30, preferably 6 to 22 and in particular 10 to 18 carbon atoms, OAIk for an -OCH 2 CH 2l -OCHCH 3 CH 2 and / or OCH 2 -CHCH 3 radical, n on average for numbers from 1 to 30, preferably 5 to 20 and in particular 10 to 15 and R 2 for a linear or branched alkyl radical having 1 to 4, preferably 1 and / or 2 carbon atoms and especially methyl.
  • Preferred acyl radicals are derived from carboxylic acids having 6 to 22 carbon atoms of natural or synthetic origin, in particular from linear, saturated and / or unsaturated fatty acids, including technical mixtures thereof, as are obtained from animal see and / or vegetable fats and oils are accessible, for example from coconut oil, palm kernel oil, palm oil, soybean oil, sunflower oil, rapeseed oil, cottonseed oil, fish oil, beef tallow and lard.
  • carboxylic acids examples include caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, arenachic acid, gadachic acid, gadoleic acid, gadoleic acid, gadic acid / galeic acid, or erucic acid.
  • AlkO stands for the alkylene oxides which are reacted with the carboxylic acid esters and include ethylene oxide, propylene oxide and / or butylene oxide, preferably ethylene oxide and / or propylene oxide, in particular ethylene oxide alone.
  • Fatty alcohol polyglycol ethers which form component (a2) are to be understood as primary aliphatic polyglycol ethers of the formula (II)
  • Polyols which form component (a3) preferably have 2 to 15 carbon atoms and at least two hydroxyl groups.
  • the polyols can also contain further functional groups, in particular amino groups, or be modified with nitrogen. Typical examples are
  • Alkylene glycols such as, for example, ethylene glycol, diethylene glycol, propylene glycol, butylene glycol, hexylene glycol and polyethylene glycols with an average molecular weight of 100 to 1,000 daltons;
  • Methyl compounds such as in particular trimethylolethane, trimethylolpropane, trimethylolbutane, pentaerythritol and dipentaerythritol;
  • Lower alkyl glucosides in particular those with 1 to 8 carbons in the alkyl radical, such as methyl and butyl glucoside;
  • Sugar alcohols with 5 to 12 carbon atoms such as sorbitol or mannitol,
  • Aminosugars such as glucamine
  • Dialcohol amines such as diethanolamine or 2-amino-1, 3-propanediol.
  • Glycerol, butylene glycol, hexylene glycol, polyethylene glycols and in particular propylene glycol with an average molecular weight in the range from 100 to 1,000 daltons are preferably used.
  • the agents according to the invention can contain components (a) in amounts of 30 to 70, preferably 40 to 60 and in particular 50% by weight.
  • the compositions comprise a mixture of (a1) alkoxylated carboxylic acid esters, preferably 45% by weight, (a2) fatty alcohol polyglycol ethers, preferably 45% by weight and (a3) polyols, preferably in particular 10% by weight.
  • Alkyl and / or alkenyl oligoglycosides which form component (a4) are known nonionic surfactants which follow the formula (III)
  • the alkyl and / or alkenyl oligoglycosides can be derived from aldoses or ketoses with 5 or 6 carbon atoms, preferably glucose.
  • the preferred alkyl and / or alkenyl oligoglycosides are thus alkyl and / or alkenyl oligoglucosides.
  • the index number p in the general formula (III) indicates the degree of oligomerization (DP), ie the distribution of mono- and oligoglycosides, and stands for a number between 1 and 10.
  • Alkyl and / or alkenyl oligoglycosides with an average degree of oligomerization p of 1.1 to 3.0 are preferably used. From an application point of view, those alkyl and / or alkenyl oligoglycosides are preferred whose degree of oligomerization is less than 1.7 and is in particular between 1.2 and 1.4.
  • the alkyl or alkenyl radical R 4 can be derived from primary alcohols having 4 to 11, preferably 8 to 10, carbon atoms. Typical examples are butanol, capronic alcohol, caprylic alcohol, capric alcohol and undecyl alcohol and their technical mixtures, such as are obtained, for example, in the hydrogenation of technical fatty acid methyl esters or in the course of the hydrogenation of aldehydes from Roelen's oxosynthesis.
  • the alkyl or alkenyl radical R 3 can also be derived from primary alcohols having 12 to 22, preferably 12 to 14, carbon atoms.
  • Typical examples are lauryl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol, brassidyl alcohol and their technical mixtures, which can be obtained as described above.
  • Alkyl oligoglucosides based on hydrogenated Ci2 / i4 coconut alcohol with a DP of 1 to 3 are preferred. Oil body
  • oil bodies which form component (b) are Guerbet alcohols based on fatty alcohols having 6 to 18, preferably 8 to 10 carbon atoms, esters of linear C6-C22 fatty acids with linear C6-C22 fatty alcohols, esters of branched C6- Ci3-carboxylic acids with linear C6-C22 fatty alcohols, esters of linear C6-C22 fatty acids with branched alcohols, especially 2-ethylhexanol, esters of hydroxycarboxylic acids with linear or branched C ⁇ -C22 fatty alcohols, especially dioctyl malates, esters of linear and / or branched fatty acids with polyhydric alcohols (such as propylene glycol, dimer diol or trimer triol) and / or Guerbet alcohols, triglycerides based on C6-C ⁇ o fatty acids, liquid mono- / di- / triglyceride mixtures based on C6-Ci8
  • the agents according to the invention can contain the oil bodies, preferably castor oil, in amounts of 70 to 30, preferably 60 to 40 and in particular 50% by weight.
  • the cosmetic preparations according to the invention can be used to produce clear, alkanol-free hair and skin care products.
  • the agents such as, for example, hair shampoos, hair lotions, foam baths, shower baths, creams, gels, lotions, alcoholic and aqueous / alcoholic solutions or emulsions, can also be used as further auxiliaries and additives, mild surfactants, emulsifiers, superfatting agents, pearlescent waxes, consistency agents, Verdic - Containing agents, polymers, silicone compounds, fats, waxes, stabilizers, biogenic agents, deodorants, anti-dandruff agents, film formers, swelling agents, UV light protection factors, antioxidants, preservatives, insect repellents, self-tanners, solubilizers, perfume oils, dyes, germ-inhibiting agents and the like.
  • Suitable mild, ie particularly skin-compatible, surfactants are monoglyceride sulfates, mono- and / or dialkyl sulfosuccinates, fatty acid isethionates, fatty acid sarcosinates, Fatty acid aurides, fatty acid glutamates, ether carboxylic acids, ⁇ -olefin sulfonates, fatty acid glucamides, alkyl amido betaines and / or protein fatty acid condensates, the latter preferably based on wheat proteins.
  • Suitable emulsifiers are nonionic surfactants from at least one of the following groups:
  • Glycerol carbonate The adducts of ethylene oxide and / or of propylene oxide with fatty acids, alkylphenols, glycerol mono- and diesters as well as sorbitan mono- and diesters with fatty acids or with castor oil are known, commercially available products. These are homolog mixtures whose average degree of alkoxylation is equivalent to that Ratio of the amounts of ethylene oxide and / or propylene oxide and substrate with which the addition reaction is carried out corresponds. Ci2 / i8 fatty acid monoesters and diesters of adducts of ethylene oxide with glycerol are known from DE 2024051 PS as refatting agents for cosmetic preparations.
  • Zwitterionic surfactants can also be used as emulsifiers.
  • Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-alkyl-NN-dimethylammonium glycinate, for example the coconut alkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate, for example the coconut acylaminopropyldimethylammonium glycinate, and 2-alkylmethyl-3-carboxyl -hydroxyethylimidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and the cocoacylaminoethylhydroxyethyl carboxymethylglycinate.
  • betaines such as the N-alkyl-NN-dimethylammonium glycinate, for example the coconut alkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate, for example the coconut
  • ampholytic surfactants are N-alkylglycine, N-alkylpropionic acid, N-alkylaminobutyric acid, N-alkyliminodipropionic acid, N-hydroxyethyl-N-alkylamidopropylglycine, N-alkyltaurine, N-alkylsarcosine, 2-alkylaminopropionic acid and alkylaminoacetic acid each with about 8 to 18 C. Atoms in the alkyl group.
  • Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and Ci2 / i8-acylsarcosine.
  • quaternary emulsifiers are also suitable, those of the esterquat type, preferably methylquaternized difatty acid triethanolamine ester salts, being particularly preferred.
  • Substances such as, for example, lanolin and lecithin and polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides can be used as superfatting agents, the latter simultaneously serving as foam stabilizers.
  • Suitable consistency agents are primarily fatty alcohols or hydroxy fatty alcohols with 12 to 22 and preferably 16 to 18 carbon atoms and, in addition, partial glycerides, fatty acids or hydroxy fatty acids.
  • a combination of these substances with alkyl oligoglucosides and / or fatty acid N-methyl glucamides of the same chain length and / or polyglycerol poly-12-hydroxystearates is preferred.
  • Suitable thickeners are, for example, Aerolsil types (hydrophilic silicas), polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose, and also higher molecular weight polyethylene glycol mono- and diesters of fatty acids, polyacrylates, (eg carbopols ® from Goodrich or Synthalene® from Sigma), polyacrylamides, polyvinyl alcohol and polyvinylpyrrolidone, surfactants such as ethoxylated fatty acid glycerides, esters of fatty acids with polyols such as pentaerythritol or trimethylolpropane, fatty alcohol ethoxylates with a narrow homolog distribution or alkyl oligoglucosides and electrolytes such as sodium chloride and ammonium chloride.
  • Aerolsil types hydrophilic silicas
  • Suitable cationic polymers are, for example, cationic cellulose derivatives, such as, for example, a quaternized hydroxyethyl cellulose, which is available under the name Polymer JR 400® from Amerchol, cationic starch, copolymers of diallylammonium salts and acrylamides, quaternized vinylpyrrolidone / vinylimidazole polymers, such as, for example, Luviquat® (BASF) , Condensation products of polyglycols and amines, quaternized collagen polypeptides, such as, for example, lauryldimonium hydroxypropyl hydrolyzed collagen (Lamequat®L / Grünau), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers, such as, for example, amidomethicones, copolymers of adipic acid and dimethylamino-hydroxypropylamine / dimethylaminohydroxyamin / sand
  • Anionic, zwitterionic, amphoteric and nonionic polymers include, for example, vinyl acetate / crotonic acid copolymers, vinylpyrrolidone / vinyl acrylate copolymers, vinyl acetate / butyl maleate isobomylacrylate copolymers, methyl vinyl ether / maleic anhydride copolymers and their esters, uncross-linked polyamide-acrylate and with polyesters trimethylammonium chloride / acrylate copolymers, octylacrylamide / methyl methacrylate / tert-butylaminoethyl methacrylate / 2-hydroxyproyl methacrylate copolymers, polyvinylpyrrolidone, vinyl pyrrolidone / vinyl acetate copolymers, vinyl pyrrolidone / dimethylaminoethyl methacrylate and silicone-in-methacrylate / vinylated acrylate / vinylated
  • Typical examples of fats are glycerides, waxes include Beeswax, carnauba wax, candelilla wax, montan wax, paraffin wax, hydrogenated castor oils, fatty acid esters or micro waxes solid at room temperature, optionally in combination with hydrophilic waxes, e.g. Cetylstearyl alcohol or partial glycerides in question.
  • Metal salts of fatty acids such as e.g. Magnesium, aluminum and / or zinc stearate or ricinoleate are used.
  • Biogenic active substances are, for example, tocopherol, tocopherol acetate, tocopherol palmitate, ascorbic acid, deoxyribonucleic acid, retinol, bisabolol, allantoin, phytantriol, panthenol, AHA acids, amino acids, ceramides, pseudoceramides, essential oils, plant extracts and vitamin complexes.
  • Antiperspirants such as aluminum chlorohydates are suitable as deodorant active ingredients. These are colorless, hygroscopic crystals that easily dissolve in the air and arise when aqueous aluminum chloride solutions are evaporated.
  • Aluminum chlorohydrate is used in the manufacture of antiperspirant and deodorant preparations and is likely to act by partially occluding the sweat glands through protein and / or polysaccharide precipitation [cf. J. Soc. Cosm.Chem. 24, 281 (1973)].
  • there is an aluminum chlorohydrate under the Locron® brand of Hoechst AG, Frankfurt / FRG that of the formula [Al2 (OH) 5CI] * 2.5 corresponds to H2O and its use is particularly preferred [cf.
  • Antibacterial agents that influence the bacterial flora and kill sweat-killing bacteria or inhibit their growth can also be contained in the stick preparations.
  • Examples include chitosan, phenoxyethanol and chlorhexidine gluconate.
  • 5-Chloro-2- (2,4-dichlorophen-oxy) phenol which is sold under the Irgasan® brand by Ciba-Geigy, Basel / CH, has also proven to be particularly effective.
  • Common film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinylpyrrolidone, vinylpyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or its salts and similar compounds.
  • UV light protection factors are understood to mean, for example, organic substances (light protection filters) which are liquid or crystalline at room temperature and which are able to absorb ultraviolet rays and release the absorbed energy in the form of longer-wave radiation, for example heat.
  • UVB filters can be oil-soluble or water-soluble. Examples of oil-soluble substances are:
  • 3-benzylidene camphor or 3-benzylidene norcampher and its derivatives e.g. 3- (4-methylbenzylidene) camphor as described in EP 0693471 B1;
  • 4-aminobenzoic acid derivatives preferably 4- (dimethylamino) benzoic acid 2-ethylhexyl ester,
  • esters of salicylic acid preferably salicylic acid 2-ethylhexyl ester, salicylic acid 4-isopropyl benzyl ester, salicylic acid homomethyl ester;
  • benzophenone preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone;
  • Esters of benzalmalonic acid preferably di-2-ethylhexyl 4-methoxybenzmalonate
  • Triazine derivatives e.g. 2,4,6-trianilino- (p-carbo-2'-ethyl-1'-hexyloxy) -1, 3,5-triazine and octyl
  • Propane-1,3-dione e.g. 1- (4-tert-butylphenyl) -3- (4'methoxyphenyl) propane-1,3-dione;
  • Ketotricyclo (5.2.1.0) decane derivatives as described in EP 0694521 B1.
  • Sulfonic acid derivatives of 3-benzylidene camphor e.g. 4- (2-oxo-3-bornylidene methyl) benzenesulfonic acid and 2-methyl-5- (2-oxo-3-bornylidene) sulfonic acid and their salts.
  • UV-A filters -4'-methoxy-dibenzoylmethane (Parsol 1789), or 1-phenyl-3- (4'-isopropylphenyl) propane-1,3-dione.
  • the UV-A and UV-B filters can of course also be used in mixtures.
  • insoluble light protection pigments namely loaned finely dispersed metal oxides or salts.
  • suitable metal oxides are, in particular, zinc oxide and titanium dioxide and, in addition, oxides of iron, zirconium, silicon, manganese, aluminum and cerium and mixtures thereof.
  • Silicates (talc), barium sulfate or zinc stearate can be used as salts.
  • the oxides and salts are used in the form of the pigments for skin-care and skin-protecting emulsions and decorative cosmetics.
  • the particles should have an average diameter of less than 100 nm, preferably between 5 and 50 nm and in particular between 15 and 30 nm. They can have a spherical shape, but it is also possible to use particles which have an ellipsoidal shape or shape which differs from the spherical shape in some other way. So-called micro- or nanopigments are preferably used in sunscreens. Micronized zinc oxide is preferably used.
  • UV light protection filters can be found in the overview by P. Finkel in S ⁇ FW-Journal 122, 543 (1996).
  • secondary light stabilizers of the antioxidant type can also be used, which interrupt the photochemical reaction chain which is triggered when UV radiation penetrates the skin.
  • Typical examples include amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (e.g. urocanic acid) and their derivatives, peptides such as D, L-camosine, D-carnosine, L-carosin and their derivatives (e.g. Anserine), carotenoids, carotenes (e.g.
  • ⁇ -carotene, ß-carotene, lycopene) and their derivatives chlorogenic acid and their derivatives, lipoic acid and their derivatives (e.g. dihydroliponic acid), aurothioglucose, propylthiouracil and other thiols (e.g.
  • thioredoxin glutathione, Cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, ⁇ -linoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximine compounds (eg buthioninsulfoximines, homocysteine sulfoximine, butioninsulfones, penta-, hexa-, himinathionin-very low sulfinoxin) compatible dosages (e.g.
  • ⁇ -hydroxy fatty acids e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g
  • ZnO, ZnS0 4 selenium and its derivatives (e.g. selenium methionine), stilbenes and their derivatives (e.g. stilbene oxide, trans-stilbene oxide) and the derivatives suitable according to the invention (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these active substances.
  • stilbenes and their derivatives e.g. stilbene oxide, trans-stilbene oxide
  • the derivatives suitable according to the invention salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids
  • Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid and the other classes of substances listed in Appendix 6, Parts A and B of the Cosmetics Ordinance.
  • N, N-diethyl-m-touiuamide, 1, 2-pentanediol or 3535 insect repellants are suitable as insect repellants, and dihydroxyacetone is suitable as a self-tanning agent.
  • Perfume oils include mixtures of natural and synthetic fragrances. Natural fragrances are extracts of flowers (lily, lavender, roses, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (anise, coriander, caraway, juniper), fruit peel (bergamot, lemon, Oranges), roots (mace, angelica, celery, cardamom, costus, iris, calmus), wood (pine, sandal, guaiac, cedar, rosewood), herbs and grasses (tarragon, lemongrass, sage, thyme), Needles and twigs (spruce, fir, pine, mountain pine), resins and balms (galbanum, elemi, benzoin, myrrh, olibanum, opoponax).
  • the ethers include, for example, benzyl ethyl ether
  • the aldehydes include, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal
  • the ketones include, for example, the jonones, oc-isomethylionone and methylcedryl ketone Anethol, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol
  • the hydrocarbons mainly include the terpenes and balsams.
  • fragrance oils which are mostly used as aroma components, are also suitable as perfume oils, e.g. sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labolanum oil and lavandin oil.
  • the dyes which can be used are those substances which are suitable and approved for cosmetic purposes, as compiled, for example, in the publication "Cosmetic Dyes” by the Dye Commission of the German Research Foundation, Verlag Chemie, Weinheim, 1984, pp. 81-106. These dyes are usually used in concentrations of 0.001 to 0.1% by weight, based on the mixture as a whole.
  • germ-inhibiting agents are preservatives with a specific action against gram-positive bacteria, such as, for example, 2,4,4'-trichloro-2'-hydroxydiphenyl ether, chlorhexidine (1,6-di- (4-chlorophenyl-biguanido) hexane) or TCC (3,4,4'-trichlorocarbanilide).
  • gram-positive bacteria such as, for example, 2,4,4'-trichloro-2'-hydroxydiphenyl ether, chlorhexidine (1,6-di- (4-chlorophenyl-biguanido) hexane) or TCC (3,4,4'-trichlorocarbanilide).
  • Numerous fragrances and essential oils also have antimicrobial properties.
  • Typical examples are the active ingredients eugenol, menthol and thymol in clove, mint and thyme oil.
  • terpene alcohol farnesol (3,7,11-trimethyl-2,6,10-dodecatrien-1-ol), which is present in the linden blossom oil and has a lily of the valley smell.
  • Glycerol monolaurate has also proven itself as a bacteriostatic.
  • the proportion of the additional germ-inhibiting substances is usually about 0.1 to 2% by weight, based on the solids content of the preparations.
  • the alkanolamide-free surfactant formulation (a) was used to produce oil baths.
  • the surfactant oil ratio and the results are summarized in Table 1.
  • the oil baths with the surfactant formulation (a) are characterized by good foam properties and good regreasing.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne de nouvelles préparations cosmétiques destinées à être utilisées pour les soins de la peau et des cheveux. Ces préparations exemptes d'alcanolamides contiennent (a) 30 à 70 % en poids d'un mélange constitué (a1) d'esters d'acide carboxylique alcoxylés, (a2) d'éthers de polyglycol d'alcool gras, (a3) de polyols, (a4) d'alkyloligoglycosides et/ou d'alkylènoligoglycosides, et (b) 70 à 30 % en poids de corps huileux, à condition que la somme des proportions indiquées soit égale à 100 % en poids.
PCT/EP2000/005173 1999-06-15 2000-06-06 Bains d'huile WO2000076459A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1999127168 DE19927168A1 (de) 1999-06-15 1999-06-15 Ölbäder
DE19927168.2 1999-06-15

Publications (2)

Publication Number Publication Date
WO2000076459A2 true WO2000076459A2 (fr) 2000-12-21
WO2000076459A3 WO2000076459A3 (fr) 2001-05-10

Family

ID=7911240

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/005173 WO2000076459A2 (fr) 1999-06-15 2000-06-06 Bains d'huile

Country Status (2)

Country Link
DE (1) DE19927168A1 (fr)
WO (1) WO2000076459A2 (fr)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2118961A (en) * 1982-04-15 1983-11-09 Firmenich & Cie Bath preparations
US5220046A (en) * 1991-08-22 1993-06-15 Vista Chemical Company Process for alkoxylation of esters and products produced therefrom
WO1994016668A1 (fr) * 1993-01-23 1994-08-04 Henkel Kommanditgesellschaft Auf Aktien Emulsions moussantes
EP0661043A1 (fr) * 1993-12-28 1995-07-05 Kao Corporation Composition tensio-active
WO1997003645A1 (fr) * 1995-07-20 1997-02-06 Pierre Fabre Dermo-Cosmetique Composition cosmetique pour hygiene corporelle sous la forme d'une emulsion huile dans l'eau
GB2318291A (en) * 1996-10-15 1998-04-22 Robin Morley Topical 8-methoxypsoralen composition
WO2000033794A2 (fr) * 1998-12-08 2000-06-15 Cognis Deutschland Gmbh Bains d'huile
WO2000053156A1 (fr) * 1999-03-10 2000-09-14 Cognis Deutschland Gmbh Bains d'huiles

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19818410A1 (de) * 1998-04-24 1999-10-28 Wella Ag Haar- und Körperreinigungsmittel mit verminderter Hautirritation

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2118961A (en) * 1982-04-15 1983-11-09 Firmenich & Cie Bath preparations
US5220046A (en) * 1991-08-22 1993-06-15 Vista Chemical Company Process for alkoxylation of esters and products produced therefrom
WO1994016668A1 (fr) * 1993-01-23 1994-08-04 Henkel Kommanditgesellschaft Auf Aktien Emulsions moussantes
EP0661043A1 (fr) * 1993-12-28 1995-07-05 Kao Corporation Composition tensio-active
WO1997003645A1 (fr) * 1995-07-20 1997-02-06 Pierre Fabre Dermo-Cosmetique Composition cosmetique pour hygiene corporelle sous la forme d'une emulsion huile dans l'eau
GB2318291A (en) * 1996-10-15 1998-04-22 Robin Morley Topical 8-methoxypsoralen composition
WO2000033794A2 (fr) * 1998-12-08 2000-06-15 Cognis Deutschland Gmbh Bains d'huile
WO2000053156A1 (fr) * 1999-03-10 2000-09-14 Cognis Deutschland Gmbh Bains d'huiles

Also Published As

Publication number Publication date
WO2000076459A3 (fr) 2001-05-10
DE19927168A1 (de) 2000-12-21

Similar Documents

Publication Publication Date Title
WO1999051199A1 (fr) Procede pour produire des nettoyants cosmetiques a viscosite elevee
WO2000033794A2 (fr) Bains d'huile
DE19910704B4 (de) Kosmetische Zubereitungen und deren Verwendung
WO2000027343A2 (fr) Preparations cosmetiques et/ou pharmaceutiques
EP1112058B1 (fr) Utilisation de carbonates cycliques comme hydratants
EP1117377B1 (fr) Preparations cosmetiques
EP1173150A1 (fr) Preparations cosmetiques et/ou pharmaceutiques
WO2001010390A2 (fr) Produit de protection solaire
EP1162941A2 (fr) Agents de protection contre le soleil
EP0992488B1 (fr) Composés d'ammonium quaternaire
EP0980683A1 (fr) Procédé de preparation d'émulsions stables
WO2000061078A2 (fr) Agents photoprotecteurs
DE19825462C2 (de) Emulgatoren
WO2001037798A1 (fr) Agent de protection solaire
WO1999066895A1 (fr) Preparations cosmetiques sous forme de baton
EP1171096B1 (fr) Preparations cosmetiques
EP1128808B1 (fr) Utilisation de melanges cationiques
WO2000027344A2 (fr) Utilisation de melanges cationiques
WO2000076459A2 (fr) Bains d'huile
WO2000027355A1 (fr) Utilisation de melanges cationiques
WO2001037791A2 (fr) Utilisation d'esters d'acide gras d'alkyle et/ou d'alcenyloligoglucoside en tant qu'agent de dispersion pigmentaire
EP0982024A2 (fr) Emulsions E/H cosmétiques et/ou pharmceutiques
WO2001037790A1 (fr) Utilisation d'esters d'acide gras d'alkyle et/ou d'alcenyloligoglucoside, afin d'ameliorer l'evaluation sensorielle d'emulsions
EP0992489A1 (fr) Betaines
DE19830374A1 (de) Kosmetische Zubereitungen

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP